2g5r: Difference between revisions
New page: left|200px<br /> <applet load="2g5r" size="450" color="white" frame="true" align="right" spinBox="true" caption="2g5r, resolution 1.600Å" /> '''Crystal structure ... |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2g5r.gif|left|200px]]<br /> | [[Image:2g5r.gif|left|200px]]<br /><applet load="2g5r" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="2g5r" size=" | |||
caption="2g5r, resolution 1.600Å" /> | caption="2g5r, resolution 1.600Å" /> | ||
'''Crystal structure of Siglec-7 in complex with methyl-9-(aminooxalyl-amino)-9-deoxyNeu5Ac (oxamido-Neu5Ac)'''<br /> | '''Crystal structure of Siglec-7 in complex with methyl-9-(aminooxalyl-amino)-9-deoxyNeu5Ac (oxamido-Neu5Ac)'''<br /> | ||
==Overview== | ==Overview== | ||
Siglecs (sialic acid binding Ig-like lectins) are transmembrane receptors | Siglecs (sialic acid binding Ig-like lectins) are transmembrane receptors for sialylated glycoconjugates that modulate cellular interactions and signalling events in the haematopoietic, immune and nervous systems. Siglec-7 is a structural prototype for the recently described family of immune inhibitory CD33-related siglecs and is predominantly expressed on natural killer cells and monocytes, as well as subsets of CD8 T-cells. Siglec-specific inhibitors are desired for the detection of masked and unmasked forms of siglecs, to aid in dissection of signalling pathways and as tools to investigate siglecs as potential therapeutic targets. As a first step towards this end, we present the crystal structure of siglec-7 in complex with a sialylated ligand, the ganglioside analogue DSLc4 [alpha(2,3)/alpha(2,6) disialyl lactotetraosyl 2-(trimethylsilyl)ethyl], which allows for a detailed description of the binding site, required for structure-guided inhibitor design. Mutagenesis and binding assays were used to demonstrate a key structural role for Lys131, a residue that changes conformation upon sialic acid binding. Differences between the binding sites of siglec family members were then exploited using alpha-methyl Neu5Ac (N-acetylneuraminic acid) as a basic scaffold. A co-crystal of siglec-7 in complex with the sialoside inhibitor, oxamido-Neu5Ac [methyl alpha-9-(amino-oxalyl-amino)-9-deoxy-Neu5Ac] and inhibition data for the sialosides gives clear leads for future inhibitor design. | ||
==About this Structure== | ==About this Structure== | ||
2G5R is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with NAG, NXD and CYS as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http:// | 2G5R is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=NAG:'>NAG</scene>, <scene name='pdbligand=NXD:'>NXD</scene> and <scene name='pdbligand=CYS:'>CYS</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2G5R OCA]. | ||
==Reference== | ==Reference== | ||
Line 14: | Line 13: | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Aalten, D | [[Category: Aalten, D M.van.]] | ||
[[Category: Attrill, H.]] | [[Category: Attrill, H.]] | ||
[[Category: Crocker, P | [[Category: Crocker, P R.]] | ||
[[Category: CYS]] | [[Category: CYS]] | ||
[[Category: NAG]] | [[Category: NAG]] | ||
Line 24: | Line 23: | ||
[[Category: siglec]] | [[Category: siglec]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:28:24 2008'' |